Chronic Myelogenous Leukemia

Donor lymophocyte infusion may resolve DIC after stem cell transplantation

Published in Blood Weekly, July 17th, 2003

Donor lymphocyte infusion (DLI) is effective for patients with advanced chronic myelogenous leukemia (CML), and may resolve coagulation defects after stem cell transplantation.

DLI "is recognized as effective therapy for relapse after stem cell transplantation" in CML patients, researchers in Japan explained. "However, the clinical efficacy of DLI in the advanced phase of CML or other types of leukemia has not been clearly defined because of its varying degree of success."

K. Matsue and colleagues at Kameda General Hospital in Chiba described the case of a "22-year-old male patient with promyelocytic crisis of CML who had a relapse after peripheral...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2003-07-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry